Sight Sciences, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US82657M1053

USD

8.34

0.04 (0.48%)

Dec 04

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Axogen, Inc.

Bioventus, Inc.

TELA Bio, Inc.

908 Devices, Inc.

Harvard Bioscience, Inc.

Sight Sciences, Inc.

Butterfly Network, Inc.

Semler Scientific, Inc.

Standard BioTools, Inc.

Celcuity, Inc.

Jin Medical International Ltd.

Why is Sight Sciences, Inc. ?

Flat results in Jun 25

ROCE(HY) Lowest at -57.1%

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 103.52%, its profits have risen by 6.4%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

50.14%

EBIT Growth (5y)

-199.36%

EBIT to Interest (avg)

-12.78

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.88

Sales to Capital Employed (avg)

0.57

Tax Ratio

0.53%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

65.14%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.80

EV to EBIT

-2.99

EV to EBITDA

-3.02

EV to Capital Employed

16.51

EV to Sales

1.90

PEG Ratio

Dividend Yield

ROCE (Latest)

-552.17%

ROE (Latest)

-63.63%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -22 MM

NET PROFIT(HY)

Higher at USD -26.09 MM

RAW MATERIAL COST(Y)

Fallen by 1.25% (YoY

-2What is not working for the Company

ROCE(HY)

Lowest at -57.1%

Here's what is working for Sight Sciences, Inc.

Operating Cash Flow

Highest at USD -22 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

Higher at USD -26.09 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Raw Material Cost

Fallen by 1.25% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales